Impact of Psychological Therapies on Emergency Medical Patients

Exploring the Transferability of Improving Access to Psychological Therapies (IAPT) to a General Hospital Emergency Inpatient Ward

Prevalence of anxiety and depression in the general population is known, but is under researched in the acute hospital setting and there is little evidence on the prevalence of anxiety and depression within the emergency medical admission population. A potential intervention for treating such mental health prevalence would be in the form of IAPT methodology which has been utilised in other parts of the NHS demonstrating good outcomes. Therefore, this feasibility study will explore the utility of IAPT in the acute setting.

This study will explore the prevalence of anxiety and depression in the emergency medical population within medical inpatient wards , utilising the assessment tools adopted by the IAPT services and explained in detail below.

The study will explore a) feasibility of introducing psychological intervention to an emergency medical ward and b) provide preliminary data on the outcome of this intervention on hospital length of stay and readmission rates.

Study Overview

• Status: Completed
• Conditions: Mental Health Disorder; Mental Health Wellness 1; Mental Disorder
• Intervention / Treatment: Other: Improving access to psychological therapies (IAPT)

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Ipswich, United Kingdom, IP4 5PD
    • East Suffolk and North Essex NHS Foundation Trust

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patients admitted to Ipswich Hospital into a ward that cares for patients who are medical emergencies.
• Patients who score 3 or higher on one or both of the GAD 2 and PHQ 2.
• Patients that have capacity to consent.
• Over 18 years old.
• Ability to speak and read in English as the study will not have the resources to employ interpreters or to get documentation translated.
• Participants that are not deemed suicidal via screening and medical and nurse assessment.

Exclusion Criteria:

• Patients not receiving care on a ward caring for medical emergencies.
• Patients under the age of 18 years old.
• Patients scoring < 3 on both GAD 2 and PHQ 2.
• Patients who do not have capacity to consent.
• Participants that are suicidal as via screening and medical and nurse assessment.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: IAPT

Other: Improving access to psychological therapies (IAPT); IAPT services provide evidence-based treatments for people with depression and anxiety disorders, and comorbid long-term physical health conditions or medically unexplained symptoms. IAPT services are characterised by three key principles: Evidence-Based psychological therapies at the appropriate dose: NICE recommended therapies matched to the mental health problem, at the intensity and duration designed to optimise outcomes.; Appropriately trained and supervised workforce.; Routine outcome monitoring.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of participants with moderate or severe anxiety	How many participants enrol in to the study, that are eligible to participate.	Up to 6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
IAPT views	Thematic analysis of in depth interviews on staff and patients regarding the IAPT intervention.	Up to 6 months

Collaborators and Investigators

• Sponsor: East Suffolk and North Essex NHS Foundation Trust
• Collaborators: University of Essex

Study record dates

Study Major Dates

• Study Start (Actual): October 10, 2021
• Primary Completion (Actual): March 27, 2022
• Study Completion (Actual): March 27, 2022

Study Registration Dates

• First Submitted: February 21, 2022
• First Submitted That Met QC Criteria: March 21, 2022
• First Posted (Actual): March 31, 2022

Study Record Updates

• Last Update Posted (Actual): July 27, 2022
• Last Update Submitted That Met QC Criteria: July 26, 2022
• Last Verified: July 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies; Disease; Mental Disorders
• Other Study ID Numbers: 20/024

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No